Patient race/ethnicity affects health care utilization, provider trust, and treatment choice. It is uncertain how these influences affect pediatric care. We performed a systematic review (PubMed, Scopus, Web of Science, PsycINFO, Cochrane, and Embase) for articles examining race/ethnicity and parental treatment decision-making, adhering to PRISMA methodology. A total of 9200 studies were identified, and 17 met inclusion criteria. Studies focused on treatment decisions concerning end-of-life care, human papillomavirus vaccination, urological surgery, medication regimens, and dental care. Findings were not uniform between studies; however, pooled results showed (1) racial/ ethnic minorities tended to prefer more aggressive end-of-life care; (2) familial tradition of neonatal circumcision influenced the decision to circumcise; and (3) non-Hispanic Whites were less likely to pursue human papillomavirus vaccination but more likely to complete the vaccine series if initiated. The paucity of studies precluded overarching findings regarding the influence of race/ethnicity on parental treatment decisions. Further investigation may improve family-centered communication, parent engagement, and shared decision-making.
Introduction
Over the past decade, an emphasis has been placed on identifying and eliminating health care disparities in the United States. 1 Racial/ethnic disparities in health care utilization have previously been attributed to poor access to care and insurance status. 2, 3 However, studies of participants in Veteran Health Administration and Medicaid demonstrated racial disparities in utilization even when differences in insurance coverage are removed. [4] [5] [6] [7] In addition to access, another factor for these disparities may be differences in treatment preferences among different racial/ethnic groups. Understanding how factors such as personal experiences and cultural and religious beliefs influence treatment decision-making among racial/ethnic groups may provide a more complete understanding of causes of health care disparities.
Racial/ethnic differences in treatment decisions have been noted across the spectrum of health care including acute and chronic conditions of lupus, end-of-life (EOL) care, rheumatoid arthritis, and mental health care. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In these cases, racial/ethnic minorities have been known to choose less aggressive treatment pathways for chronic medical conditions, such as use of drugs with fewer side effects or use of single drugs rather than multiple, but these same groups choose more aggressive EOL maneuvers. These trends have been attributed to the impact of spirituality on racial/ethnic minority decision-making. These decisions may also be due to poor understanding of the benefits and risks of certain procedures or medications, as well as mistrust of clinicians.
Pediatric care involves treatment decisions made by parents, guardians, and caregivers on behalf of the child. Parental decision-making may also influence future health-seeking behavior of the child. We performed a mixed-methods systematic review of existing research that examined race/ethnicity and parental treatment decisions in pediatric care.
Methods

Search Strategy
We performed a systematic review of 6 electronic databases (PubMed, Scopus, Web of Science, PsycINFO, Cochrane, and Embase) using combinations of the following key terms and synonyms in English language publications: "decision-making," "parent," "child," "pediatric," "race," and "ethnic groups." A university informationist oversaw the database search for completeness and reproducibility. A primary literature search was performed from November 16 to December 22, 2016 . We adhered to the PRISMA (Preferred Reporting Items for Systematic Reviews and MetaAnalyses) checklist and statement recommendations during development of this systematic review protocol. 18 The study protocol is registered with PROSPERO, an international prospective registry of systematic reviews. 19 
Inclusion Criteria
We included quantitative and qualitative studies that (1) involved at least one non-Hispanic White racial/ethnic group, (2) described a parental treatment decision made in pediatric health care, and (3) were written in the English language. Only studies that involved an explicit treatment decision were included. Additionally, studies were excluded if they did not meet inclusion criteria, did not state the treatment decision that was studied, pertained to non-pediatric (>18 years) patients, did not include written abstracts, or did not include original research with human subjects (eg, review articles). There were no restrictions based on publication date. Studies occurring outside of the United States were excluded due to inherent differences in health system administration and operations.
Screening and Data Extraction
Titles and abstracts were initially assessed to eliminate those articles not related to the stated topic. Title and abstract screenings were performed independently by 7 reviewers. Reviewers were divided into reviewer pairs with citations divided equally among the reviewer pairs. Articles that were eliminated included books, clinical guidelines, conference notes, generalized treatment preferences, reviews, studies specific to adult subjects, and studies that lacked primary data. Reviewer conflicts were resolved by a third reviewer. The articles that met inclusion criteria were then read in full by 2 reviewers. If, on review, an article no longer appeared to meet inclusion criteria, the reason was noted and the article was not included in the review. If after this analysis an article was still found to have met inclusion criteria, the data were extracted and included in the review. Data extracted included author, publication year, study purpose, study design, setting, study participants, racial/ ethnic minority group distribution, clinical scenario, treatment decision, and key findings. Coauthors independently performed data extraction using a predesigned data extraction form.
Data Synthesis
Studies were classified based on treatment decision type. The decision types in the included articles were the following: EOL care, human papillomavirus (HPV) vaccination, urological procedures, and medication decisions.
Quality Assessment
Study quality was assessed using the Mixed Methods Appraisal Tool (MMAT), a validated assessment tool that allows for quality assessment of qualitative, quantitative, and mixed-methods studies. 20 The quality of quantitative descriptive studies are appraised on criteria relating to 4 questions on sampling strategy, selection of representative sample, appropriate measurements, and acceptable response rate. The quality of qualitative studies are appraised on criteria relating to 4 questions on use of relevant data source, process of data analysis, if consideration was given to how findings related to the setting in which they were collected, and how the researchers may have influenced findings. Each study is given a score ranging from 0% to 100%. 21 Mixedmethods studies are given a score for the quantitative and qualitative portions of the study with an overall score not exceeding the score of its weakest component. No studies were excluded based on quality assessment.
Results
The search identified a total of 14 420 articles: PubMed search produced 2936 articles, Embase search produced 2131 articles, Cochrane search produced 176 articles, Scopus search produced 4839 articles, Web of Science search produced 1626 articles, and PsycINFO search produced 2712 articles. Seventeen articles met the inclusion criteria. Figure 1 summarizes the results of the literature search and review process. The most common reasons for exclusion were that the study focused on adult participants, was performed in a non-US location, and/or did not involve a treatment decision made. Table  1 lists the characteristics of included studies.
Of the 17 included studies, 4 focused on EOL care, 5 focused on HPV vaccination, 4 focused on urological procedures, 3 focused on medication decisions, and 1 focused on dental care. The majority of studies were quantitative (n = 10). Overall, there were 19 266 combined participants in the 17 studies with White and Hispanics being the largest racial/ethnic groups, 39% (n = 7506) and 37.5% (n = 7242), respectively. Cohort sizes were varied among studies, and racial/ethnic groups were not equally distributed. Twelve of the studies compared more than one racial/ethnic group, one study 33 included 95% Black and 5% White participants with no comparisons made between the groups. Of the remaining studies, 1 included Black participants only, and 3 included Hispanic participants only. Table 2 lists results of quality assessment using the MMAT. 21 Scores ranged from 50% to 100%. For most quantitative studies, score reduction was due to a response rate below 60% and/or sampling strategy. Few qualitative studies gave consideration for how study findings were influenced by the researchers and the setting in which the data were collected. life-sustaining therapy compared with Black families although the difference was not statistically significant per authors (80% vs 62%; P not reported). 22 Edmonds et al found that Whites were less likely than Blacks to use intubation in periviable infants born between 20 through 25 weeks gestation (odds ratio [OR] = 1.25, 95% confidence interval [CI] = 1.07-1.46; P = .005). 23 The remaining 2 studies focused on hospice enrollment and EOL care for older children. Thienprayoon et al found that race/ethnicity was significantly associated with hospice enrollment (49% Hispanic, 34% non-Hispanic White; P = .02), and Hispanic patients were more likely to enroll in hospice when compared with White patients (OR = 5.96, 95% CI = 1.45-31.04). 24 In contrast, Baker et al found there was no racial/ethnic difference noted in the number of do-not-resuscitate orders (84.21% White, 87.25% Black; P = .57) or rate of hospice enrollment (41.6% Black, 44% White; P = .64). 25 Table 4 lists summary of findings for the 5 studies on HPV vaccination. A 2010 study by Perkins et al found no racial/ethnic variation in receipt of HPV vaccination for daughters of low-income parents, with an 89% vaccination acceptance rate overall. 26 The study obtained qualitative data concerning parental decision-making on HPV vaccination, which revealed that parents who intended to vaccinate had similar concerns to those that refused vaccination but thought that the benefits outweighed the risks; however, these responses were not attributed to a particular race/ethnicity. In a study of factors associated with caregivers' decisions to pursue HPV vaccination for their children, Barboza et al found that Whites were least likely to vaccinate (28.6% Hispanic, 22.4% Black, 20.4% White; P < .01). However, White caregivers were more likely to complete all 3 doses if initiated (38.6% Hispanic, 53.5% Black, 58.9% White; P < .01). 27 A 2013 study by Perkins et al examining HPV vaccination rates for sons of low-income parents found that Hispanics had a higher vaccination rate compared with Whites and Blacks (59% vs 21% vs 22%, respectively, P < .01). 28 A study by Bastani et al assessing HPV vaccine uptake and correlates among low-income, ethnic minority girls found that 29% of mothers initiated vaccination for their daughters with a 12% completion rate with no significant racial/ethnic differences (P = .295, .305, respectively). The study found racial/ethnic differences in HPV vaccine awareness. While around 60% of Hispanic, Chinese, and Black mothers were aware of HPV vaccine, only 44% of Korean mothers had heard of it (P = .029). They also found racial/ethnic differences in vaccination beliefs. For example, 8% of Hispanic and 11% of Black mothers thought their daughters had a higher risk of HPV infection compared with other girls (P < .001). 29 Finally, a study by Thomas et al examining HPV vaccination preferences of rural Black parents found that non-Baptist (OR = 3.6, 95% CI = 2.00-6.60, P < .001) and higher levels of education were associated with a greater intention to vaccinate (n = 393, P =.050). 30 Three studies focused on parental decisions about circumcision. A study by Bisono et al 32 consisting of a largely Hispanic cohort found only 33% of the cohort had circumcised their sons. Parents who identified with cultures that believed in circumcision (Wald χ 2 = 5.03, P ⩽ .0001), families believing in circumcising boys (Wald χ 2 = 6.1, P = .014), and believing circumcision to not be too risky (Wald χ 2 = 20.5, P ⩽ .0001) influenced the decision to circumcise. 32 A study by Ahaghotu et al consisting of Black parents found that 96% believed that circumcision is healthy, 72% believed that it is a necessary procedure, 41% indicated health reasons as the most important factor for choosing circumcision, and 25% selected maternal preference as the main factor with the mother being 12 times more likely than the father to make the final decision. 33 In the one study that compared racial/ethnic groups, Binner et al found that 85% of participants opted for circumcision with no difference in circumcision rates among the different groups. 34 Table 6 lists summary of findings for the 3 studies on decisions about medication use and one study on dental care. A study by Leslie et al on attention-deficit/hyperactivity disorder medication decisions involving 28 families found that all 8 families in the reluctant receipt of diagnosis and/or medication treatment category were Hispanic, meaning they did not actively participate in at least one stage of the diagnosis and treatment trajectory pattern defined by the study. 35 There were no comparisons made between racial/ethnic groups. A study by Alegría et al using classification and regression tree methods to create a classification model of use versus nonuse of pediatric mental health among Hispanic caregivers found that perceived impairment, concern about the child, and school problems predicted use of mental health services (sensitivity = 0.83, specificity = 0.67). 36 A study by Valenzuela et al examining racial/ethnic differences in regimen intensity in children with type 1 diabetes found that White, non-Hispanic youth was associated with higher rates of more intense treatment regimens use compared with Blacks and Hispanics (51.4% vs 0% vs 23.8%, respectively; P < .01). Parent perception of cost (P = .001) and the provider's perception of family competence in diabetes care (P = .01) was associated with a preference for less intensive regimen. 37 In a qualitative study examining low-income Mexican immigrant caregivers' interpretations of their children's dental symptoms and need for treatment, Horton and Barker found that dental visits were obtained when both pain and poor appearance were evident. 38 
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Discussion
In this systematic review, we examined studies on race/ ethnicity and treatment decisions made in pediatrics. The existing literature examining race/ethnicity and parental specific treatment decision-making in pediatric care is surprisingly sparse. We identified 17 studies that described treatment decisions made in 5 areas of clinical care: EOL care, urological procedures, HPV vaccination, medication decisions, and dental care. Although findings on racial/ethnic based differences in treatment decisions were not uniform, they do illuminate key factors, which play a role in parental health care treatment decision-making.
Racial/ethnic differences in EOL care decisionmaking have been noted in the adult literature, where racial/ethnic minorities often seek more aggressive care and are less likely to enroll in hospice care. [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] The Edmonds et al and Moseley et al studies included in this analysis mirror these findings, where parents of racial/ ethnic minorities were more likely to seek aggressive EOL care. 22, 23 However, findings related to hospice care differed with one study indicating that Hispanics were more likely than Whites to enroll in hospice and another finding no racial/ethnic differences in hospice enrollment rate between Black and White families. 24 The included studies regarding HPV vaccination focused on vaccination decisions made among lowincome families and racial/ethnic minorities due to the prevalence of higher rates of HPV infection. Individuals belonging to these groups also have less access to screening and treatment for cervical cancer leading to higher mortality rates compared with the overall population. [49] [50] [51] [52] [53] Most of the included studies on HPV vaccination found no racial/ethnic differences in HPV vaccination acceptance rates; this trend may affect reduction of future cervical cancer racial disparities.
Circumcision has become a contentious topic over recent years, and neonatal male circumcision rates have • • 41% indicated health reasons as the most important factor for choosing circumcision.
• • 25% selected maternal preference as the main factor.
• • The mother was 12 times more likely than the father to make the final decision.
• • 72% believed that it is a necessary procedure.
a Study included 10 non-Hispanic parents but data for race not included. Race/ethnicity plays a significant role in health care access and outcomes. [58] [59] [60] [61] As the medical community prioritizes patient-centered outcomes, it is important to dedicate time to understanding parent and family preferences in addition to individual patient preferences. The selected research studies focused on racial/ethnic treatment decisions with limited qualitative data to explain treatment preferences. Overall, there is limited data on the effect of racial/ethnic treatment preferences in health outcomes in pediatrics, and there is no large data set available to use to test hypotheses regarding racial/ethnic treatment preferences in pediatric care. In order to prevent instances where preferences may differ due to poor understanding of disease course and treatment risks and benefits providers should engage in fully informed shared decision-making. The clinical topics included in this review only represent a small subset of pediatric health care needs; additional studies covering a wide range of clinical topics are needed.
There are several limitations to this systematic review. Findings must be considered in light of limitations regarding small sample size and nonvalidated questionnaires in some of the studies. The participants in several of the studies are those who went to the doctor and may not be generalizable due to selection bias. The studies also used parental report that may lead to bias and overestimation of vaccination rates in particular. None of the selected studies indicated that power analysis was performed, and nonsignificant findings may be due to the studies being underpowered. This systematic review focused on treatment decisions made by parents and the included studies do not specifically explore general decision-making, factors influencing parental decision-making, or engagement in care.
Conclusion
The existing patient-oriented scientific literature on race/ethnicity and medical treatment decisions made for children is limited. The few studies that were analyzed in this systematic review showed that parents of racial/ ethnic minorities tend to prefer more aggressive EOL care, and newborn circumcision is mainly influenced by familial traditions and culture. We also found racial/ethnic differences in HPV vaccination with non-Hispanic Whites being less likely to pursue HPV vaccination but more likely to complete the vaccine series if initiated. Additional research is needed to explore influences on treatment preferences for different racial/ethnic groups. Expanding the body of research on this topic may aid in the development of culturally competent communication and education materials for parents making treatment decisions for their child.
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